These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 6220848

  • 1. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
    Naama JK, Mitchell WS, Zoma A, Veitch J, Whaley K.
    Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
    [Abstract] [Full Text] [Related]

  • 2. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.
    Schifferli JA, Steiger G, Hauptmann G, Spaeth PJ, Sjöholm AG.
    J Clin Invest; 1985 Dec; 76(6):2127-33. PubMed ID: 2934406
    [Abstract] [Full Text] [Related]

  • 3. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G, Petersen I, Jensenius JC, Svehag SE.
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [Abstract] [Full Text] [Related]

  • 4. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D, Barnett EV, Yamagata J, Knutson D, Restivo C, Furst D.
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [Abstract] [Full Text] [Related]

  • 5. Control of immune complexes by the classical pathway.
    Whaley K, Ahmed AE.
    Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
    [Abstract] [Full Text] [Related]

  • 6. Complement, antigen-antibody complexes and immune complex disease.
    Naama JK, Niven IP, Zoma A, Mitchell WS, Whaley K.
    J Clin Lab Immunol; 1985 Jun; 17(2):59-67. PubMed ID: 2931531
    [No Abstract] [Full Text] [Related]

  • 7. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T, Fujita T, Kono I, Kabashima T, Yamane K, Tamura N, Kashiwagi H.
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [Abstract] [Full Text] [Related]

  • 8. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
    Kerr MA, Wilton E, Naama JK, Whaley K.
    Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA, Hay FC, Poulton TA.
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [Abstract] [Full Text] [Related]

  • 10. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ, Steinsson K, Kolka R, Víkingsdóttir T, D'Ambrogio MS, Valdimarsson H.
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [Abstract] [Full Text] [Related]

  • 11. Detection of soluble immune complexes by the technique of ADCC inhibition in human diseases.
    Meyer O, Descamps B.
    J Clin Lab Immunol; 1979 Nov; 2(4):311-8. PubMed ID: 537026
    [Abstract] [Full Text] [Related]

  • 12. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
    Weissmann G.
    Bull NYU Hosp Jt Dis; 2009 Nov; 67(3):251-3. PubMed ID: 19852746
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
    Scullion M, Balint G, Whaley K.
    J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 15. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS, Naama JK, Veitch J, Whaley K.
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [Abstract] [Full Text] [Related]

  • 16. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM, van Es LA, Daha MR.
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [Abstract] [Full Text] [Related]

  • 17. Studies of circulating immune complexes in ankylosing spondylitis.
    Kinsella TD, Lanteigne C, Lewkonia RM, Fritzler MJ.
    Clin Invest Med; 1982 Jun; 5(4):223-30. PubMed ID: 7160109
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK, Mitchell WS, Whaley K.
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [Abstract] [Full Text] [Related]

  • 19. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
    Hunder GG, McDuffie FC, Huston KA, Elveback LR, Hepper NG.
    J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
    [Abstract] [Full Text] [Related]

  • 20. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G, Karsh J, Osterland CK.
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.